Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1990 Aug;153(2):199–202.

Valproic acid-associated encephalopathy.

G L Jones 1, F Matsuo 1, J R Baringer 1, W H Reichert 1
PMCID: PMC1002521  PMID: 2219888

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batshaw M. L., Brusilow S. W. Valproate-induced hyperammonemia. Ann Neurol. 1982 Mar;11(3):319–321. doi: 10.1002/ana.410110315. [DOI] [PubMed] [Google Scholar]
  2. Bourrier P., Varache N., Alquier P., Rabier D., Kamoun P., Lorre G., Alhayek G. Oedème cérébral avec hyperammoniémie au cours d'une intoxication par le valpromide. Révélation, chez un adulte, d'un déficit partiel en carbamylphosphate synthétase de type I. Presse Med. 1988 Nov 5;17(39):2063–2066. [PubMed] [Google Scholar]
  3. Campostrini R., Paganini M., Boncinelli L., Zaccara G., Arnetoli G., Zappoli R. Alterazioni dello stato di coscienza indotte da acido valproico: osservazione di sei casi. Riv Patol Nerv Ment. 1983 Jan-Feb;104(1):23–34. [PubMed] [Google Scholar]
  4. Chadwick D. W., Cumming W. J., Livingstone I., Cartlidge N. E. Acute intoxication with sodium valproate. Ann Neurol. 1979 Dec;6(6):552–553. doi: 10.1002/ana.410060616. [DOI] [PubMed] [Google Scholar]
  5. Coulter D. L., Allen R. J. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet. 1980 Jun 14;1(8181):1310–1311. doi: 10.1016/s0140-6736(80)91773-0. [DOI] [PubMed] [Google Scholar]
  6. Donat J. F., Bocchini J. A., Jr, Gonzalez E., Schwendimann R. N. Valproic acid and fatal hepatitis. Neurology. 1979 Feb;29(2):273–274. [PubMed] [Google Scholar]
  7. Gaskins J. D., Holt R. J., Postelnick M. Nondosage-dependent valproic acid-induced hyperammonemia and coma. Clin Pharm. 1984 May-Jun;3(3):313–316. [PubMed] [Google Scholar]
  8. Gerber N., Dickinson R. G., Harland R. C., Lynn R. K., Houghton L. D., Antonias J. I., Schimschock J. C. Reye-like syndrome associated with valproic acid therapy. J Pediatr. 1979 Jul;95(1):142–144. doi: 10.1016/s0022-3476(79)80110-9. [DOI] [PubMed] [Google Scholar]
  9. Haidukewych D., John G., Zielinski J. J., Rodin E. A. Chronic valproic acid therapy and incidence of increases in venous plasma ammonia. Ther Drug Monit. 1985;7(3):290–294. doi: 10.1097/00007691-198507030-00009. [DOI] [PubMed] [Google Scholar]
  10. Herranz J. L., Arteaga R., Armijo J. A. Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients. Epilepsia. 1982 Apr;23(2):203–214. doi: 10.1111/j.1528-1157.1982.tb05068.x. [DOI] [PubMed] [Google Scholar]
  11. Iinuma K., Hayasaka K., Narisawa K., Tada K., Hori K. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid. Eur J Pediatr. 1988 Dec;148(3):267–269. doi: 10.1007/BF00441418. [DOI] [PubMed] [Google Scholar]
  12. Janssen F., Rambeck B., Schnabel R. Acute valproate intoxication with fatal outcome in an infant. Neuropediatrics. 1985 Nov;16(4):235–238. doi: 10.1055/s-2008-1059544. [DOI] [PubMed] [Google Scholar]
  13. Kugoh T., Yamamoto M., Hosokawa K. Blood ammonia level during valproic acid therapy. Jpn J Psychiatry Neurol. 1986 Dec;40(4):663–668. doi: 10.1111/j.1440-1819.1986.tb03182.x. [DOI] [PubMed] [Google Scholar]
  14. König S., Scheffner D., Rauterberg-Ruland I., Kochen W., Hofmann W. J., Wokittel E., Schick U. Tödliches Leberversagen bei einem altersgemäss entwickelten fünf Jahre alten Jungen unter VPA-Monotherapie. Monatsschr Kinderheilkd. 1987 Jun;135(6):310–313. [PubMed] [Google Scholar]
  15. Marescaux C., Warter J. M., Micheletti G., Rumbach L., Coquillat G., Kurtz D. Stuporous episodes during treatment with sodium valproate: report of seven cases. Epilepsia. 1982 Jun;23(3):297–305. doi: 10.1111/j.1528-1157.1982.tb06195.x. [DOI] [PubMed] [Google Scholar]
  16. Murphy J. V., Marquardt K. Asymptomatic hyperammonemia in patients receiving valproic acid. Arch Neurol. 1982 Sep;39(9):591–592. doi: 10.1001/archneur.1982.00510210061016. [DOI] [PubMed] [Google Scholar]
  17. Ratnaike R. N., Schapel G. J., Purdie G., Rischbieth R. H., Hoffmann S. Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs. Br J Clin Pharmacol. 1986 Jul;22(1):100–103. [PMC free article] [PubMed] [Google Scholar]
  18. Rawat S., Borkowski W. J., Jr, Swick H. M. Valproic acid and secondary hyperammonemia. Neurology. 1981 Sep;31(9):1173–1174. doi: 10.1212/wnl.31.9.1173. [DOI] [PubMed] [Google Scholar]
  19. Sackellares J. C., Lee S. I., Dreifuss F. E. Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia. 1979 Dec;20(6):697–703. doi: 10.1111/j.1528-1157.1979.tb04853.x. [DOI] [PubMed] [Google Scholar]
  20. Schmid R. D. Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid. Clin Chim Acta. 1977 Jan 3;74(1):39–42. doi: 10.1016/0009-8981(77)90385-0. [DOI] [PubMed] [Google Scholar]
  21. Sills J. A., Jones R. H., Taylor W. H. Valproate, hyperammonemia, and hyperglycinemia. Lancet. 1980 Aug 2;2(8188):260–261. [PubMed] [Google Scholar]
  22. Suchy F. J., Balistreri W. F., Buchino J. J., Sondheimer J. M., Bates S. R., Kearns G. L., Stull J. D., Bove K. E. Acute hepatic failure associated with the use of sodium valproate. N Engl J Med. 1979 Apr 26;300(17):962–966. doi: 10.1056/NEJM197904263001706. [DOI] [PubMed] [Google Scholar]
  23. Sussman N. M., McLain L. W., Jr A direct hepatotoxic effect of valproic acid. JAMA. 1979 Sep 14;242(11):1173–1174. [PubMed] [Google Scholar]
  24. Tartara A., Manni R. Sodium valproate "encephalopathy": report of three cases with generalised epilepsy. Ital J Neurol Sci. 1985 Mar;6(1):93–95. doi: 10.1007/BF02229225. [DOI] [PubMed] [Google Scholar]
  25. Thurston J. H., Carroll J. E., Hauhart R. E., Schiro J. A. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance. Life Sci. 1985 Apr 29;36(17):1643–1651. doi: 10.1016/0024-3205(85)90367-4. [DOI] [PubMed] [Google Scholar]
  26. Turnbull D. M., Dick D. J., Wilson L., Sherratt H. S., Alberti K. G. Valproate causes metabolic disturbance in normal man. J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):405–410. doi: 10.1136/jnnp.49.4.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Williams C. A., Tiefenbach S., McReynolds J. W. Valproic acid-induced hyperammonemia in mentally retarded adults. Neurology. 1984 Apr;34(4):550–553. doi: 10.1212/wnl.34.4.550. [DOI] [PubMed] [Google Scholar]
  28. Young R. S., Bergman I., Gang D. L., Richardson E. P., Jr Fatal Reye-like syndrome associated with valproic acid. Ann Neurol. 1980 Apr;7(4):389–389. doi: 10.1002/ana.410070423. [DOI] [PubMed] [Google Scholar]
  29. Zaccara G., Paganini M., Campostrini R., Arnetoli G., Zappoli R., Moroni F. Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases. Eur Neurol. 1984;23(2):104–112. doi: 10.1159/000115687. [DOI] [PubMed] [Google Scholar]
  30. Zaccara G., Paganini M., Campostrini R., Moroni F., Valenza T., Messori A., Bartelli M., Arnetoli G., Zappoli R. Effect of associated antiepileptic treatment on valproate-induced hyperammonemia. Ther Drug Monit. 1985;7(2):185–190. doi: 10.1097/00007691-198506000-00008. [DOI] [PubMed] [Google Scholar]
  31. van Egmond H., Degomme P., de Simpel H., Dierick A. M., Roels H. A suspected case of late-onset sodium-valproate-induced hepatic failure. Neuropediatrics. 1987 May;18(2):96–98. doi: 10.1055/s-2008-1052461. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES